These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21787232)

  • 21. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Li J; Nghiem P; Detwiler DA; Larsen CA; Grange RW; Bhavaraju-Sanka RK; Tou S; Keene BP; Howard JF; Wang J; Fan Z; Schatzberg SJ; Styner MA; Flanigan KM; Xiao X; Hoffman EP
    Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy.
    Wang J; Fan Z; Vandenborne K; Walter G; Shiloh-Malawsky Y; An H; Kornegay JN; Styner MA
    Int J Comput Assist Radiol Surg; 2013 Sep; 8(5):763-74. PubMed ID: 23299128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splitting of Pi and other ³¹P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy.
    Wary C; Naulet T; Thibaud JL; Monnet A; Blot S; Carlier PG
    NMR Biomed; 2012 Oct; 25(10):1160-9. PubMed ID: 22354667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy.
    Schatzberg SJ; Anderson LV; Wilton SD; Kornegay JN; Mann CJ; Solomon GG; Sharp NJ
    Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.
    Schneider SM; Sridhar V; Bettis AK; Heath-Barnett H; Balog-Alvarez CJ; Guo LJ; Johnson R; Jaques S; Vitha S; Glowcwski AC; Kornegay JN; Nghiem PP
    Mol Imaging Biol; 2018 Oct; 20(5):780-788. PubMed ID: 29508262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prednisone in canine muscular dystrophy.
    Liu JM; Okamura CS; Bogan DJ; Bogan JR; Childers MK; Kornegay JN
    Muscle Nerve; 2004 Dec; 30(6):767-73. PubMed ID: 15468337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural History of Histopathologic Changes in Cardiomyopathy of Golden Retriever Muscular Dystrophy.
    Schneider SM; Sansom GT; Guo LJ; Furuya S; Weeks BR; Kornegay JN
    Front Vet Sci; 2021; 8():759585. PubMed ID: 35252412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological comparison of the smooth uterine muscle of healthy golden retriever bitches, carriers of the progressive muscular dystrophy (GRMD) gene, and GRMD-affected bitches.
    Brolio MP; Cima DS; Miglino MA; Ambrósio CE
    Anim Reprod Sci; 2014 Nov; 150(1-2):56-61. PubMed ID: 25200710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic myostatin decrease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin proteasome system despite enhancing the severity of disease.
    Cotten SW; Kornegay JN; Bogan DJ; Wadosky KM; Patterson C; Willis MS
    Am J Transl Res; 2013; 6(1):43-53. PubMed ID: 24349620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy.
    Estrellas KM; Chung L; Cheu LA; Sadtler K; Majumdar S; Mula J; Wolf MT; Elisseeff JH; Wagner KR
    J Biol Chem; 2018 Oct; 293(40):15594-15605. PubMed ID: 30139748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvessel density in muscles of dogs with golden retriever muscular dystrophy.
    Nguyen F; Guigand L; Goubault-Leroux I; Wyers M; Cherel Y
    Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy.
    Fan Z; Wang J; Ahn M; Shiloh-Malawsky Y; Chahin N; Elmore S; Bagnell CR; Wilber K; An H; Lin W; Zhu H; Styner M; Kornegay JN
    Neuromuscul Disord; 2014 Feb; 24(2):178-91. PubMed ID: 24295811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
    BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle percentage index as a marker of disease severity in golden retriever muscular dystrophy.
    Eresen A; Hafsa NE; Alic L; Birch SM; Griffin JF; Kornegay JN; Ji JX
    Muscle Nerve; 2019 Nov; 60(5):621-628. PubMed ID: 31397906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients.
    Duan D
    Hum Gene Ther; 2018 Jul; 29(7):733-736. PubMed ID: 29463117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Texture as an imaging biomarker for disease severity in golden retriever muscular dystrophy.
    Eresen A; Alic L; Birch SM; Friedeck W; Griffin JF; Kornegay JN; Ji JX
    Muscle Nerve; 2019 Mar; 59(3):380-386. PubMed ID: 30461036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Chu C; Balog-Alvarez C; Yu X; Cai JJ; Nabity M; Kornegay JN
    PLoS One; 2018; 13(3):e0194485. PubMed ID: 29554127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.
    Park J; Wicki J; Knoblaugh SE; Chamberlain JS; Lee D
    PLoS One; 2015; 10(4):e0124914. PubMed ID: 25856443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.